Target intelligence / Profile preview

Major histocompatibility complex class I beta2-microglobulin (None)

Target
None
Molecular classification
Protein, MHC Class I component
01

Overview

Beta2-microglobulin (β2M) is a small, highly conserved protein that forms an essential component of the major histocompatibility complex class I (MHC I) molecules. MHC I molecules are present on the surface of nearly all nucleated cells and play a critical role in immune surveillance by presenting peptide antigens to cytotoxic T lymphocytes (CTLs). It is non-covalently associated with the α chain of MHC class I molecules and is crucial for maintaining the proper conformation and stability of the MHC class I heavy chain. β2M also associates with several other "class-I like" proteins such as CD1 family members, MR1, neonatal Fc receptor (FcRn), Qa antigens in mice, and human hemochromatosis protein (HFE). Dysregulation or deficiency in β2-microglobulin can lead to immunodeficiency syndromes. Elevated serum levels are used as biomarkers for certain diseases including some cancers and chronic inflammatory conditions. Some pathogens have evolved mechanisms targeting β2-microglobulin, such as Cytomegalovirus and Mycobacterium tuberculosis.

Other names
β2-microglobulinB2M
02

Mechanism of action

N/A

03

Biological functions

Antigen presentationMHC Class I stabilizationImmune responseProtein foldingProtein transport
04

Disease associations

ImmunodeficiencyCancerInflammationIron overload disorders
05

Safety considerations

Dysregulation leads to immunodeficiencyPotential target for pathogen immune evasion
06

Biomarkers

Elevated serum β2M levels

Beyond the preview

Go deeper on Major histocompatibility complex class I beta2-microglobulin (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major histocompatibility complex class I beta2-microglobulin (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call